The OnTrack Diabetes Web-based Program for Type 2 Diabetes and Dysphoria Self-Management: A Randomised Controlled Trial
- Conditions
- Type 2 diabetesDysphoriaPublic Health - Health promotion/educationMental Health - Other mental health disordersMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12614001126606
- Lead Sponsor
- Queensland University of Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 210
(a) Type 2 diabetes diagnosis (by a medical doctor and/ according to WHO criteria) for 3 or more months; (b) aged 18 years or older; (c) living in Australia without plans to leave within 12 months; (d) regular computer and internet access ; (e) contactable by phone; (f) clear command of written English (at least year 5 education); and (g) stable diabetes pharmacotherapy (medication dose stable for past 4 weeks; medication type stable past 3 months).
(a) current diagnosis of mental disorder other than depression or anxiety (participant is asked if a condition has been diagnosed and if so they are informed that they will receive access to the program but not be included in the trial); (b) current suicidal risk (assessed via suicide risk assessment); (c) significant cognitive disorder (e.g. from head trauma or dementia); (d) currently on steroid medication , or likely to commence these in the next 12 months; (e) pregnant or likely to become pregnant in the next 12 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence behaviours (assessed using questionnaires - Serves of fruit, vegetables, sweets, and fat per week (new survey designed for OnTrack Diabetes to assess diet), Active Australia Survey (physical activity), AusDiab Study Survey (medication + blood sugar testing)[Baseline, 3, 6 months];Mental health (assessed by questionnaires - Depression, Anxiety, Stress Scale; Diabetes Distress Scale)[Baseline, 3 and 6 months]
- Secondary Outcome Measures
Name Time Method HbA1c (assessed by blood sample from their GP)[Baseline, 3, and 6 months];Quality of Life (EQ-5D)[baseline, 3, 6 months];Self Efficacy (Diabetes Self-Efficacy Scale)[Baseline, 3, 6 months]